Table 1.
Patients’ demographic characteristics and disease-related parameters in patients with juvenile systemic lupus erythematosus and juvenile idiopathic arthritis.
| Characteristics | JSLE n= (21) | JIA n= (30) |
|---|---|---|
| Age (years) | 15.8 (2.25) | 14.5 (2.27) |
| Height (m) | 1.61 (0.09) | 1.58 (0.07) |
| Bodyweight (kg) | 61.1 (18.8) | 62.2 (15.6) |
| BMI (kg/m2) | 23.1 (5.27) | 24.3 (5.58) |
| Female, n (%) | 16 (76.1) | 24 (80) |
| Disease time (years) | 6.45 (3.90) | 5.20 (4.78) |
| Age at the disease onset (years) | 9.66 (3.48) | 9.36 (3.68) |
| Prednisone, n (%) | 11 (52%) | 3 (10%) |
| Dosage mg/day | 10 (5–22.5) | 10 (10–17.5) |
| Methotrexate, n (%) | 4 (19%) | 8 (27%) |
| Dosage mg/day | 17.5 (11.2–23.7) | 25 (20–25) |
| Leflunomide, n (%) | 1 (5%) | 11 (30%) |
| Dosage mg/day | 20 | 20 (20–20) |
| HCQ, n (%) | 20 (95%) | 1 (3%) |
| Dosage mg/day | 400 (200–400) | 200 (200–200) |
| Adalimumab n (%) | 0 (0) | 3 (%) |
| Dosage mg/day | 40 (40–40) | |
| Etanercept, n (%) | 0 (0) | 3 (10%) |
| Dosage mg/day | 50 (50–50) |
Values are described in mean (SD) or median ITQ (25–75). Abbreviations: JSLE: juvenile systemic lupus erythematosus; JIA: juvenile idiopathic arthritis; BMI: body mass index; HCQ: hydroxychloroquine.